Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Annuities > Variable Annuities

Financial advisors are losing faith in insurers

By Danielle Andrus

X
Your article was successfully shared with the contacts you provided.

Financial advisors are losing faith in insurers. That’s what a survey of Merrill Lynch advisors found, the Wall Street Journal reports.

According to the survey, conducted in February 2009 by Banc of America Securities-Merrill Lynch, over 70 percent of financial advisors said “they were concerned about the risks insurers have taken on with guaranteed-minimum variable annuities.” To add insult to injury, close to one-third doubted the insurers themselves understand the risks.

At the time of the survey, about two dozen insurers’ ratings had slipped, the Journal writes, “although most remain at least for now in categories denoting capitalization that is ‘strong’ to ‘very strong.’”

However, “[t]he ratings firms assigned a negative outlook to many of the insurers for the next 12 to 18 months and put some on watch for possible additional downgrade over the next few months.”

In the period between when the survey was conducted and when the survey results were published, insurers addressed some of the risks associated with their products, according to the Journal. Many insurers started limiting how aggressive their products were by cutting payouts and increasing the costs to new customers; others suspended guarantees pending regulatory approval of revised products. It’s too soon, however, to determine just how far this trend will go.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.